MagForce Nanotechnologies completes clinical trial of Nano-Cancer therapy in glioblastoma patients (News-Medical-Net)

MagForce Nanotechnologies AG has successfully completed its single-arm clinical trial on the efficacy of thermotherapy using superparamagnetic nanoparticles in patients with recurrent glioblastoma.
(read the story…)

Related items

• MagForce Nanotechnologies AG reaches primary study endpoint in pivotal glioblastoma study (Business Wire via Yahoo! Finance)
• Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval Of Nano-Cancer(R) Therapy (Medical News Today)
• MagForce Nanotechnologies Completes Patient Recruitment For Pivotal Glioblastoma Study (Medical News Today)
• MagForce Nanotechnologies Completes Patient Recruitment for Pivotal Glioblastoma Study (Business Wire via Yahoo! Finance)
• MagForce Nanotechnologies applies for EU regulatory approval of its Nano-Cancer therapy (News-Medical-Net)

Tags: cancer, cancer therapy, efficacy, magforce, magnetic nanoparticles, nano, nanoparticle, nanoparticles, nanotech, nanotechnologie, nanotechnologies, recurrent glioblastoma, thermotherapy, trial

This entry was posted on Wednesday, November 4th, 2009 at 4:50 pm and is filed under Business.